▸ 3 Sep 2026, 08:21 FDA Accepts Imricor PMA Manufacturing Module Company Update
▸ 28 Aug 2026, 17:17 Release from Voluntary Escrow Securities Administration
▸ 28 Aug 2026, 08:16 Imricor and Philips Launch Commercial iMR Lab Solution Company Update
▸ 10 Aug 2026, 08:50 Imricor U.S. Commercial Momentum Accelerates Company Update
▸ 10 Aug 2026, 08:39 1H 2026 Investor Presentation Presentations
▸ 10 Aug 2026, 08:39 2026 Q2 Form 10-Q Periodic Reports
▸ 10 Aug 2026, 08:38 Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission Periodic Reports
▸ 7 Aug 2026, 08:31 Philips Declares Compatibility with Imricor Company Update
▸ 4 Aug 2026, 08:58 Q2 FY26 Results Webinar Notification Presentations
▸ 27 Jul 2026, 08:34 Imricor Launches U.S. Commercial Operations Company Update
▸ 20 Jul 2026, 09:25 Imricor Submits All Remaining 510(k) Devices to FDA Company Update
▸ 14 Jul 2026, 17:19 Notification regarding unquoted securities - IMR Securities Administration
▸ 13 Jul 2026, 11:35 Cleansing Notice Securities Administration
▸ 13 Jul 2026, 11:30 Application for quotation of securities - IMR Securities Administration
▸ 2 Jul 2026, 08:33 Imricor Receives FDA Pediatric Clearances for iMR Device Company Update
▸ 26 Jun 2026, 08:58 Form S-8 Registration Statement Securities Administration
▸ 11 Jun 2026, 08:55 Submission of the Third PMA Module to the US FDA for Review Company Update
▸ 27 May 2026, 09:13 Granting of ASX Waiver - US Financial Reporting Requirements Securities Administration
▸ 21 May 2026, 09:36 Notification of cessation of securities - IMR Securities Administration
▸ 21 May 2026, 09:33 Update - Notification regarding unquoted securities - IMR Securities Administration
▸ 20 May 2026, 09:57 Appendix 3Y - AD Director Interests
▸ 20 May 2026, 09:56 Appendix 3Y - PM Director Interests
▸ 20 May 2026, 09:56 Appendix 3Y - AM Director Interests
▸ 20 May 2026, 09:55 Appendix 3Y - MT Director Interests
▸ 20 May 2026, 09:53 Appendix 3Y - SW Director Interests
▸ 20 May 2026, 09:34 Notification regarding unquoted securities - IMR Securities Administration
▸ 19 May 2026, 18:00 Becoming a substantial holder Substantial Holders
▸ 18 May 2026, 09:44 Application for quotation of securities - IMR Securities Administration
▸ 18 May 2026, 09:26 Amendment to Form 10 Company Update
▸ 8 May 2026, 12:09 Results of Meeting Meetings & Governance
▸ 8 May 2026, 10:37 Cleansing Notice Securities Administration
▸ 8 May 2026, 10:33 Application for quotation of securities - IMR Securities Administration
▸ 8 May 2026, 09:27 Release from Voluntary Escrow Securities Administration
▸ 8 May 2026, 08:23 AGM Presentation Slides Presentations
▸ 8 May 2026, 08:22 Chair's Address for AGM Letters & Addresses
▸ 4 May 2026, 09:49 Equity Raising Presentation Presentations
▸ 4 May 2026, 09:12 Proposed issue of securities - IMR Securities Administration
▸ 4 May 2026, 09:12 Imricor Completes Successful A$60 Million Capital Raise Capital Raising
▸ 30 Apr 2026, 09:59 Trading Halt Trading Halt / Suspension
▸ 30 Apr 2026, 09:51 Pause in Trading Trading Halt / Suspension
▸ 28 Apr 2026, 08:25 Imricor Q1 CY26 Quarterly Activities Report and Appendix 4C Quarterly Reports
▸ 27 Apr 2026, 08:43 Amendment to Form 10 Company Update
▸ 16 Apr 2026, 16:15 Notification regarding unquoted securities - IMR Securities Administration
▸ 8 Apr 2026, 08:44 Imricor Submits NorthStar for U.S. Pediatric Expansion Company Update
▸ 27 Mar 2026, 09:26 Notice of Annual Stockholders Meeting and CDI Voting Form Presentations
▸ 27 Mar 2026, 09:24 Annual Report to shareholders Financial Results
▸ 27 Mar 2026, 09:20 Appendix 4G and Corporate Governance Statement Company Administration
▸ 19 Mar 2026, 09:02 Form 10 Registration with the U.S. SEC Company Update
▸ 25 Feb 2026, 07:45 FY25 Results Investor Presentation Financial Results
▸ 25 Feb 2026, 07:45 Imricor Releases FY25 Results Financial Results
▸ 25 Feb 2026, 07:44 Appendix 4E and FY25 Financial Accounts Financial Results
▸ 18 Feb 2026, 09:37 Na Homolce to Become 3rd Site for VISABL-VT Company Update
▸ 17 Feb 2026, 09:39 FY25 Results Webinar Presentations
▸ 6 Feb 2026, 08:53 Imricor Submits Advantage-MR System for FDA 510(K) Clearance Company Update
▸ 3 Feb 2026, 08:57 Oklahoma Heart Institute to Become 4th US VISABL-AFL Site Company Update
▸ 29 Jan 2026, 08:36 Imricor Receives FDA Clearance for NorthStar Company Update
▸ 28 Jan 2026, 09:24 Imricor Q4 CY25 Quarterly Activities Report and Appendix 4C Quarterly Reports
▸ 21 Jan 2026, 09:13 VCU Health to Become Third U.S. Site for VISABL-AFL Company Update
▸ 20 Jan 2026, 16:26 Change in substantial holding from CGF Substantial Holders
▸ 20 Jan 2026, 16:19 Change in substantial holding Substantial Holders
▸ 14 Jan 2026, 10:19 Notification of cessation of securities - IMR Securities Administration
▸ 13 Jan 2026, 09:10 Notification regarding unquoted securities - IMR Securities Administration
▸ 12 Jan 2026, 08:28 FDA Clears VISION-MR Diagnostic Catheter Company Update
▸ 19 Dec 2025, 09:47 Charite to Become 2nd Site for VISABL-VT Company Update
▸ 15 Dec 2025, 08:23 UVA Health to Become Second U.S. Site for VISABL-AFL Company Update
▸ 10 Nov 2025, 09:18 Initial Director's Interest Notice Director Interests
▸ 10 Nov 2025, 08:54 Imricor Appoints Aldo Denti to Board of Directors Company Administration
▸ 4 Nov 2025, 09:21 First in Human Ischemic VT Ablation Performed in iCMR Company Update
▸ 28 Oct 2025, 09:11 Cleansing Notice Securities Administration
▸ 27 Oct 2025, 09:18 Application for quotation of securities - IMR Securities Administration
▸ 22 Oct 2025, 09:42 Imricor Q3 CY25 Quarterly Activities Report and Appendix 4C Quarterly Reports
▸ 21 Oct 2025, 08:46 Canaccord Drug & Device Conference Noosa 2025 Presentation Presentations
▸ 20 Oct 2025, 08:57 Imricor Performs World's First PFA Ablation in the iCMR Company Update
▸ 13 Oct 2025, 09:48 Notification of cessation of securities - IMR Securities Administration
▸ 10 Oct 2025, 10:35 Notification regarding unquoted securities - IMR Securities Administration
▸ 18 Sep 2025, 08:53 Imricor Completes Human Factors Study for FDA Company Update
▸ 15 Sep 2025, 11:13 Application for quotation of securities - IMR Securities Administration
▸ 8 Sep 2025, 13:07 Application for quotation of securities - IMR Securities Administration
▸ 1 Sep 2025, 09:19 Submission of FDA 510(k) Approval for Vision-MR Diagnostic Company Update
▸ 28 Aug 2025, 10:27 Release from Voluntary Escrow Securities Administration
▸ 26 Aug 2025, 08:06 H1 FY25 Results Investor Presentation Financial Results
▸ 26 Aug 2025, 08:06 Imricor releases Half Year Results for 1H 2025 Financial Results
▸ 26 Aug 2025, 08:05 Appendix 4D and Half Year Report & Accounts Financial Results
▸ 15 Aug 2025, 11:32 FY25 1H Results Webinar Notification Presentations
▸ 13 Aug 2025, 08:33 Canaccord 45th Annual Growth Conference Presentation Presentations